Silvie Karson
Bio
Passionate storyteller exploring the world of trends. With a background in digital marketing, I craft compelling narratives that inform and inspire. Whether diving into deep-dive features, growth analysis, or trend analysis.
Stories (122)
Filter by community
Convenience Meets Care: Why Smart Pet Feeders Market is in Demand
Smart pet feeders are here to stay, as trends in urban lifestyles and pet humanization gain momentum. An in-demand category among millennials and Gen Z, smart feeders are projected to register a significant CAGR through 2030, driven by needs for high-precision, connected, data-driven pet care.
By Silvie Karson7 months ago in Journal
2024–2030: Bipolar Electrosurgical Devices Market on the Rise
As surgical interventions become more sophisticated, precise, and less invasive, the use of bipolar electrosurgical devices is becoming more and more frequent in modern operating rooms around the world. Bipolar electrosurgical instruments give surgeons a secure and reliable way to cut tissue and stop bleeding with less danger and greater control than other techniques. They are a vital tool for improving patient outcomes and shortening recovery times in a variety of surgical disciplines, including general surgery, gynecology, neurosurgery, and urology, among others.
By Silvie Karson7 months ago in Journal
What’s Driving the Fondaparinux Market? A Look Ahead to 2030
Fondaparinux is a synthetic, pentasaccharide anticoagulant that selectively inhibits factor Xa in the coagulation cascade. It is used both in hospital and outpatient settings for the prophylaxis and treatment of venous thromboembolism (VTE). Compared to low molecular weight heparins (LMWHs), Fondaparinux has a lower risk of HIT due to lack of binding to platelet factor 4.
By Silvie Karson7 months ago in Journal
Assuring Purity: What’s Driving the Biopharmaceuticals Manufacturing Consumables Testing Market?
In the world of vaccines and monoclonal antibodies, purity isn’t just a buzzword: it’s a matter of life and death. The biopharmaceutical production process is one of the most complex chains of dependencies in manufacturing. The purity and safety of a single-use system (SUS) is only as good as the quality of materials that go into it. That’s why biopharmaceuticals manufacturing consumables testing, which verifies the integrity of packaging, filters, tubing, bags, and media, has become a critical gatekeeper function in pharma and biotech companies.
By Silvie Karson7 months ago in Journal
Why the Network Emulator Market Is Booming in the 5G Era
Complexity, higher performance demands, and dynamic new network characteristics are turbo-charging the need for more, and more realistic, high-fidelity test environments. This is driving a once sleepy, niche market for network emulators to new heights of growth with a predicted compound annual growth rate of close to 7.7% from 2024 to 2030 and market size poised to breach over USD 446.9 million million in the next few years.
By Silvie Karson7 months ago in Journal
Exploring the Surge in the Edge AI Software Market Worldwide
The Worldwide Edge AI Software Market: Growth, Trends, and Forecasts (2024-2030) is a report produced by The Research Insights. The Global Edge AI Software Market was valued at USD 579.74 million in 2021 and it is expected to reach USD 1.95 billion by 2024, at a CAGR of 28.8% for the forecast period of 2024 to 2030.
By Silvie Karson7 months ago in Journal
Drug Discovery Informatics Market Surges to $7.03 Billion – Powered by Cloud Computing, AI Platforms, and Pharma Collaborations
By 2030, the global market for drug discovery informatics solutions has reached a valuation of $7.03 billion, marking a new era in the search for new therapies, targets, and treatments.
By Silvie Karson7 months ago in Journal
A $14.53 Billion Revolution in Care: AI in Precision Medicine Market Expands with Leaders Like Microsoft, PathAI, and Illumina
With a market worth of $14.53 billion by 2030, the AI in precision medicine market is emerging as a game-changer in the healthcare industry. Precision medicine – the tailoring of treatment to the individual characteristics of each patient – has long promised to revolutionize healthcare.
By Silvie Karson7 months ago in Journal
The Rise of Dementia Treatment Market: A $28.11 Billion Industry Driven by Aging Populations – Led by Biogen, Eisai, and Eli Lilly
This neurological disorder, characterized by progressive memory loss, cognitive decline, and behavioral changes, has emerged as one of the most urgent and costly public health challenges of the 21st century. As a result, there is a pressing global need for better diagnostic tools, more effective therapies, and comprehensive care models. The dementia treatment market, currently valued at $28.11 billion, is expected to witness significant growth in the coming years. This growth is being propelled by factors like demographic shifts, increased public awareness, and advancements in pharmaceutical research and development. Key industry players driving this growth include Biogen, Eisai, and Eli Lilly, among others, through the development of innovative therapies that target disease-modifying and symptomatic care.
By Silvie Karson7 months ago in Journal
The Rise of Precision Imaging: Near Infrared Imaging Market Hits $2.82 Billion – Key Players Include Novadaq, Medtronic, and Quest Medical Imaging
The global Near Infrared Imaging market size has reached a value of $2.82 billion, propelled by the increasing demand for precision diagnostics, image-guided surgery, and minimally invasive interventions. As healthcare systems transition towards real-time, data-driven decision-making, near infrared imaging is emerging as a key technology, with potential to improve clinical outcomes in oncology, cardiology, and neurology.
By Silvie Karson7 months ago in Journal
Mental Health in Focus: Anxiety and Depression Treatment Market Grows to $19.28 Billion – Driven by SSRIs, Therapy Tech, and Major Players Like Johnson & Johnson and AbbVie
The global anxiety and depression treatment market size is now at $19.28 billion by 2030 as mental health is increasingly recognized as a priority for public health. Demand is growing as a result of rising diagnoses, changing attitudes, and access to digital therapy platforms. Selective serotonin reuptake inhibitors, cognitive behavioral therapies, and new treatment modalities are leading the way. Companies such as Johnson & Johnson and AbbVie are actively pursuing drug launches, innovation pipelines, and investments.
By Silvie Karson7 months ago in Journal
